Castle Creek Arbitrage, LLC Gilead Sciences, Inc. Call Options Transaction History

Castle Creek Arbitrage, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.85 Million - $2.1 Million	-32,600 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $4.19 Million - $5.26 Million	-67,400 Reduced 67.4%	32,600 $2.06 Million
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $6.26 Million - $8.02 Million	100,000 New	100,000 $7.48 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Castle Creek Arbitrage, LLC, based on Form 13F filings with the SEC.

Stay updated on Castle Creek Arbitrage, LLC with notifications on news.